Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 10, 1997, Pages 1939-1946

  Durand, Philippe ^a   Prost, Michel ^b   Blache, Denis ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CEDRA   (France)

Author keywords

Folic acid; Homocysteine; Oral contraceptives; Oxidative stress; Platelet function

Indexed keywords

ARACHIDONIC ACID; ETHINYLESTRADIOL PLUS LYNESTRENOL; FOLIC ACID; THIOBARBITURIC ACID; THROMBIN; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; LIPID PEROXIDATION; NONHUMAN; ORAL CONTRACEPTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RISK FACTOR; SMOKING; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS;

EID: 0031442166     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.10.1939     Document Type: Article

References (17)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
2. Malinow MR. Hyperhomocyst(e)inemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 1990;81:2004-2006.
3. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
4. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL, Gore TB, Cornwell PE, Roseman JM. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940-948.
5. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
6. Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47-53.
7. Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis. 1996;121:231-243.
8. Royal College of General Practitioners'. Oral contraception study: mortality among oral-contraceptive users. Lancet. 1977;2:727-731.
9. Kaplan NM. Cardiovascular complications of oral contraceptives. Annu Rev Med. 1978;29:31-40.
10. Meade TW. Risks and mechanisms of cardiovascular events in users of oral contraceptives. Am J Obstet Gynecol. 1988;158:1646-1652.
11. Inauen W, Baumgartner HR, Haeberli A, Straub PW. Excessive deposition of fibrin, platelets and platelet thrombi on vascular subendothelium during contraceptive drug treatment. Thromb Haemost. 1987;57:306-309.
12. Beller FK, Ebert C. Effects of oral contraceptives on blood coagulation: a review. Obstet Gynecol Surv. 1985;40:425-436.
13. Ciavatti M, Davenas E, Blache D, Monnier A, Renaud S. Biosynthesis of platelet lipids in relation to aggregation in women using oral contraceptives. Contraception. 1982;25:629-638.
14. Ciavatti M, Davenas E, Blache D, Renaud S. Vitamin E prevents the platelet abnormalities induced by estrogen in rat. Contraception. 1984;30:279-287.
15. Durand P, Blache D. Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats. Atherosclerosis. 1996;121:205-216.
16. Shojania AM. Oral contraceptives: effects on folate and vitamin B12 metabolism. Can Med Assoc J. 1982;126:244-247.
17. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med. 1989;114:473-501.